Spark Therapeutics (ONCE) Misses Q3 EPS by 28c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Spark Therapeutics (ONCE) Misses Q3 EPS by 28c

B.Riley/FBR Upgrades Spark Therapeutics (ONCE) to Buy

November 7, 2018 3:47 AM EST

B.Riley/FBR analyst Madhu Kumar upgraded Spark Therapeutics (NASDAQ: ONCE) from Neutral to Buy with a price target of $71.00 (from $68.00).

For an analyst ratings summary and ratings history on Spark Therapeutics click here. For more ratings news on Spark Therapeutics click here.

Shares of Spark Therapeutics closed at $41.68 yesterday.

... More

Spark Therapeutics (ONCE) PT Lowered to $48 at BMO Capital

November 6, 2018 3:55 PM EST

BMO Capital analyst Matthew Luchini lowered the price target on Spark Therapeutics (NASDAQ: ONCE) to $48.00 (from $60.00) while maintaining a Market Perform rating.

The analyst believes weakness in the stock reflects continued uncertainty on the outlook for SPK-8011 for hemophilia A.

"We... More